-- Scott Roberts
THURSDAY, Dec. 1 (HealthDay News) -- The first generic version
of the cholesterol-lowering statin Lipitor (atorvastatin calcium)
has been approved by the U.S. Food and Drug Administration.
Drug maker Ranbaxy Laboratories, based in India, has gained
approval to produce the tablets in 10 milligram (mg), 20 mg, 40 mg
and 80 mg strengths, the FDA said in a news release. The agency
stressed that makers of generic drugs are required to pass the same
production- and packaging-quality standards as producers of
People with above-normal levels of low-density lipoprotein (LDL,
the so-called "bad" cholesterol), are at greater risk of heart
attack and stroke when LDL levels build up in the arteries and
inhibit blood flow. Lipitor blocks an enzyme in the liver, helping
to lower levels of LDL and another form of blood cholesterol,
In clinical trials for the brand-name Lipitor, produced by
Pfizer, the most common side effects included nasal inflammation,
joint pain, diarrhea and urinary tract infection.
To learn more about this approval, visit the
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.
Copyright © EBSCO Publishing. All rights reserved.